Literature DB >> 9552369

Phosphorylation of elongation factor-1 (EF-1) by cdc2 kinase.

R Bellé1, O Minella, P Cormier, J Morales, R Poulhe, O Mulner-Lorillon.   

Abstract

Elongation factor-1 (EF-1) is a major substrate for cdc2 kinase in Xenopus oocytes. The guanine-nucleotide exchange factor EF-1 beta gamma delta, appears to have a highly complex macromolecular structure containing several GTP/GDP exchange proteins, valyl-tRNA synthetase, and a putative anchoring protein EF-1 gamma. During meiotic cell division, the factor becomes phosphorylated by cdc2 kinase, not only on EF-1 gamma, but also on two different phospho-acceptors on EF-1 delta. Phosphorylation is concomitant with changes in protein synthesis in vivo. Xenopus oocytes, and potentially all cells, contain a multitude of heteromeric forms of the complex which postulates that EF-1 beta gamma delta is not a "house keeping" factor but a sophisticated regulatory element.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9552369     DOI: 10.1007/978-1-4615-1809-9_21

Source DB:  PubMed          Journal:  Prog Cell Cycle Res        ISSN: 1087-2957


  11 in total

1.  The role of cdc2 in the expression of herpes simplex virus genes.

Authors:  S J Advani; R R Weichselbaum; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

2.  The 3' untranslated region of human vimentin mRNA interacts with protein complexes containing eEF-1gamma and HAX-1.

Authors:  May Al-Maghrebi; Hervé Brulé; Marina Padkina; Carrie Allen; W Michael Holmes; Zendra E Zehner
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

3.  Mapping the human translation elongation factor eEF1H complex using the yeast two-hybrid system.

Authors:  Francisco Mansilla; Irene Friis; Mandana Jadidi; Karen M Nielsen; Brian F C Clark; Charlotte R Knudsen
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

4.  FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis.

Authors:  H Ishii; A Vecchione; Y Murakumo; G Baldassarre; S Numata; F Trapasso; H Alder; R Baffa; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

5.  FEZ1/LZTS1 is down-regulated in high-grade bladder cancer, and its restoration suppresses tumorigenicity in transitional cell carcinoma cells.

Authors:  Andrea Vecchione; Hideshi Ishii; Gustavo Baldassarre; Pierfrancesco Bassi; Francesco Trapasso; Hansjuerg Alder; Francesco Pagano; Leonard G Gomella; Carlo M Croce; Raffaele Baffa
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

6.  Mutation of a conserved CDK site converts a metazoan Elongation Factor 1Bbeta subunit into a replacement for yeast eEF1Balpha.

Authors:  J R Pomerening; L Valente; T G Kinzy; T W Jacobs
Journal:  Mol Genet Genomics       Date:  2003-07-30       Impact factor: 3.291

7.  Early cytokinin response proteins and phosphoproteins of Arabidopsis thaliana identified by proteome and phosphoproteome profiling.

Authors:  Martin Cerny; Filip Dycka; Janette Bobál'ová; Bretislav Brzobohaty
Journal:  J Exp Bot       Date:  2010-10-25       Impact factor: 6.992

8.  Deoxycytidine kinase regulates the G2/M checkpoint through interaction with cyclin-dependent kinase 1 in response to DNA damage.

Authors:  Chunying Yang; Michael Lee; Jianwei Hao; Xiaoli Cui; Xiaojing Guo; Caroline Smal; Françoise Bontemps; Shumei Ma; Xiaodong Liu; David Engler; William B Parker; Bo Xu
Journal:  Nucleic Acids Res       Date:  2012-07-31       Impact factor: 16.971

9.  Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2.

Authors:  Christian C Witt; Stephanie H Witt; Stefanie Lerche; Dietmar Labeit; Walter Back; Siegfried Labeit
Journal:  EMBO J       Date:  2007-12-20       Impact factor: 11.598

10.  Regulated interaction between polypeptide chain elongation factor-1 complex with the 26S proteasome during Xenopus oocyte maturation.

Authors:  Toshinobu Tokumoto; Ayami Kondo; Junko Miwa; Ryo Horiguchi; Mika Tokumoto; Yoshitaka Nagahama; Noriyuki Okida; Katsutoshi Ishikawa
Journal:  BMC Biochem       Date:  2003-07-16       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.